HLLY vs THRM vs MPAA vs DORM

For growth investors, Dorman Products, Inc.

(DORM) is the stronger pick with 6. 0% revenue growth year-over-year, versus 1. 9% for Holley Inc. (HLLY). Holley Inc. (HLLY) offers the better valuation at 15. 8x trailing P/E (7. 4x forward), making it the more compelling value choice. Analysts rate Holley Inc. (HLLY) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Holley Inc.

(HLLY) is the cheapest at 15. 8x versus Gentherm Incorporated at 51. 4x. On forward P/E, Holley Inc. is actually cheaper at 7. 4x.

Over the past 5 years, Dorman Products, Inc.

(DORM) delivered a total return of +19. 2%, compared to -74. 8% for Holley Inc. (HLLY). Over 10 years, the gap is even starker: DORM returned +129. 7% versus HLLY's -74. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Dorman Products, Inc.

(DORM) is the lower-risk stock at 0. 85β versus Holley Inc. 's 1. 94β — meaning HLLY is approximately 128% more volatile than DORM relative to the S&P 500. On balance sheet safety, Gentherm Incorporated (THRM) carries a lower debt/equity ratio of 41% versus 116% for Holley Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Dorman Products, Inc.

(DORM) is pulling ahead at 6. 0% versus 1. 9% for Holley Inc. (HLLY). On earnings-per-share growth, the picture is similar: Holley Inc. grew EPS 180. 0% year-over-year, compared to -70. 9% for Gentherm Incorporated. Over a 3-year CAGR, THRM leads at 7. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Dorman Products, Inc.

(DORM) is the more profitable company, earning 9. 6% net margin versus -2. 6% for Motorcar Parts of America, Inc. — meaning it keeps 9. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DORM leads at 16. 8% versus 5. 2% for THRM. At the gross margin level — before operating expenses — HLLY leads at 41. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Holley Inc.

(HLLY) trades at 7. 4x forward P/E versus 15. 3x for Motorcar Parts of America, Inc. — 7. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HLLY: 148. 0% to $6. 25.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Dorman Products, Inc.

(DORM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 85), +129. 7% 10Y return). Holley Inc. (HLLY) carries a higher beta of 1. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DORM: +129. 7%, HLLY: -74. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: HLLY is a small-cap deep-value stock; THRM is a small-cap quality compounder stock; MPAA is a small-cap quality compounder stock; DORM is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.